2021
DOI: 10.1016/j.hlc.2021.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Outcomes Following Rapid Access Chest Pain Clinic Assessment: First Australian Data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…Rapid access chest pain services were also successfully launched in Australia and China since 2008 12–15. The introduction of a once weekly half day nurse-led RACPC in Hobart increased the number of patients with a definitive diagnosis at the first clinic visit, reduced unplanned ED attendances and major adverse cardiovascular events in the following year, when compared with a historical control previously treated in the cardiology outpatients clinic 13…”
Section: Discussionmentioning
confidence: 99%
“…Rapid access chest pain services were also successfully launched in Australia and China since 2008 12–15. The introduction of a once weekly half day nurse-led RACPC in Hobart increased the number of patients with a definitive diagnosis at the first clinic visit, reduced unplanned ED attendances and major adverse cardiovascular events in the following year, when compared with a historical control previously treated in the cardiology outpatients clinic 13…”
Section: Discussionmentioning
confidence: 99%
“…Four studies reported the operating of RACCs to be safe 2,6,14,24 . Studies reported no patient mortality while awaiting follow‐up, 2,6,14 with a low number of RACC patients (1%) requiring direct admission to hospital for invasive coronary angiography and 0.5% having ACS ( n = 3; one with non‐ST‐elevation myocardial infarction and two with unstable angina) 2 .…”
Section: Safetymentioning
confidence: 99%
“…In one long term study, after adjusting for age, sex, hypertension, diabetes, smoking and dyslipidaemia, patients attending a RACC had fewer major adverse cardiovascular events at 12 months compared with a historical control (adjusted odds ratio [OR], 0.09; 95% CI, 0.02–0.46) 14 . Another study that explored differences in all‐cause mortality between a RACC cohort ( n = 1133; mean follow‐up, 6.3 years; standard deviation, 2.6 years) against an age‐ and sex‐matched general population control (people in NSW over the same study period) 24 found lower all‐cause mortality in the RACC cohort group for the patients aged 55–64 years ( n = 292; mortality rate per patient‐year 0.33 v expected mortality rate per year 0.63; relative risk [RR] of death, 0.53; P = 0.01), 65–74 years ( n = 182; 0.54 v 1.76; RR = 0.31; P < 0.001) and 75 years or older ( n = 62; 4.33 v 7.77; RR = 0.56; P < 0.001), with no differences in all‐cause mortality for patients aged 16–54 years 24 …”
Section: Safetymentioning
confidence: 99%